Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM

Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women

Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339 · see citing works

Nuclear Receptors and the Control of Metabolism

Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. H. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 632 · see citing works

Thiazolidinediones: a new class of antidiabetic drugs

Day, C. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00023.x · Cited by 435 · see citing works

PPARγ AND G LUCOSE H OMEOSTASIS

Picard, F., & Auwerx, J. H. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.010402.102808 · Cited by 412 · see citing works

Intermediate metabolism in normal pregnancy and in gestational diabetes

Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., & Del Prato, S. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.390 · Cited by 406 · see citing works

Evaluation of insulin sensitivity in clinical practice and in research settings

Monzillo, L. U., & Hamdy, O. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.dec.397-412 · Cited by 259 · see citing works

Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments

Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231 · see citing works

Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.

Cavaghan, M. K., Ehrmann, D. A., Byrne, M. M., & Polonsky, K. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119562 · Cited by 216 · see citing works

Prevalence and risk factors for gestational diabetes assessed by universal screening

Cianni, G. D., Volpe, L., Lencioni, C., Miccoli, R., Cuccuru, I., Ghio, A., Chatzianagnostou, K., Bottone, P., Teti, G. C., Prato, S. D., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.07.004 · Cited by 182 · see citing works

THIAZOLIDINEDIONES

Henry, R. R. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70267-x · Cited by 152 · see citing works

TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

Azen, S., Peters, R., Berkowitz, K., Kjos, S., Xiang, A., & Buchanan, T. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00151-7 · Cited by 164 · see citing works

Gestational Diabetes: Implications for Cardiovascular Health

Sullivan, S. D., Umans, J. G., & Ratner, R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-011-0238-3 · Cited by 143 · see citing works

Treatment of prediabetes

Kanat, M., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1207 · Cited by 84 · see citing works

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction

Lenhard, J. M., Lancaster, M. E., Paulik, M. A., Weiel, J. E., Binz, J. G., Sundseth, S. S., Gaskill, B., Lightfoot, R. M., & Brown, H. R. (1999) · Diabetologia · doi:10.1007/s001250051193 · Cited by 82 · see citing works

Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus

Parker, J. C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00093-5 · Cited by 69 · see citing works

Update on Gestational Diabetes

Pridjian, G. C., & Benjamin, T. D. (2010) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2010.02.017 · Cited by 52 · see citing works

Risk Factors for Progression From Gestational Diabetes to Postpartum Type 2 Diabetes: A Review

Bengtson, A. M., Ramos, S. Z., Savitz, D. A., & Werner, E. F. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000585 · Cited by 32 · see citing works

Redefining the clinical management of type 2 diabetes: matching therapy to pathophysiology

Gerich, J. E. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.6.x · Cited by 31 · see citing works

β‐cell deterioration – prospects for reversal or prevention

Finegood, D. T., & Topp, B. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00030.x · Cited by 27 · see citing works

Postpartum Care of the Woman With Diabetes

Kjos, S. L. (2000) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200003000-00008 · Cited by 26 · see citing works

Current Views on the Mechanism of Action of Thiazolidinedione Insulin Sensitizers

Goldstein, B. J. (1999) · Diabetes Technology & Therapeutics · doi:10.1089/152091599317189 · Cited by 26 · see citing works

Hepatotoxicity of thiazolidinediones

Isley, W. L., & Oki, J. C. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00159.x · Cited by 24 · see citing works

Effects of Troglitazone in Young First-Degree Relatives of Patients With Type 2 Diabetes

Levin, K., Nielsen, O. H., Henriksen, J. E., & Beck‐Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.148 · Cited by 18 · see citing works

Diagnostic Criteria and Classification of Diabetes

Leu, J. P., & Zonszein, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_7 · Cited by 11 · see citing works

Effects of pioglitazone on beta-cell function in metabolic syndrome patients with impaired glucose tolerance

Jin, J., Yu, Y., Yu, H., Wang, C., & Zhang, X. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.020 · Cited by 9 · see citing works

Prevención de la diabetes mellitus tipo 2

Vidal, J. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)70991-8 · Cited by 6 · see citing works

Oral hypoglycemic agents for noninsulin-dependent diabetes mellitus in the cat

Greco, D. S. (1997) · Topics in companion animal medicine · doi:10.1016/s1096-2867(97)80018-7 · Cited by 6 · see citing works

Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.

Dea, M. K., Citters, G. W. V., Ader, M., Mittelman, S. D., Sunehag, A. L., & Bergman, R. N. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2087 · Cited by 6 · see citing works

Prediabetes: challenges and opportunities

Моргунова, Т. Б., Glinkina, I. V., & Fadeev, V. V. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-220-227 · Cited by 5 · see citing works

Thiazolidinediones as PPAR Agonists

Mudaliar, S. R. D., & Henry, R. R. (2004) · doi:10.1002/0470862092.d0611 · Cited by 3 · see citing works

Prevention of Type 2 and Gestational Diabetes

Hamman, R. F., & Dabelea, D. (2010) · doi:10.1002/9780470682807.ch5

Effects of rosiglitazone pretreatment on blood glucose, lipid levels, urea, and microalbuminuria in rats undergoing 70% pancreatectomy

Yetışır, F., Acar, Şenel, O. O., Bukan, Yürekli, & Salman (2013) · Open Access Surgery · doi:10.2147/oas.s39364

Effects of high-dose troglitazone on insulin sensitivity and β-cell function in watanabe heritable hyperlipidemic rabbits

Zhang, B., Shiomi, M., Tanaka, H., Mei, J., Fan, P., Tsujita, Y., Horikoshi, H., & Saku, K. (2001) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190395

Nutrient Interactions and Glucose Homeostasis

Opara, E. C. (2005) · CRC Press eBooks · doi:10.1201/9781420038798.ch10

Diabetes gestacional

Sánchez, L. F. P., & de la Morena, L. H. (2001) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(01)75484-9

Effect of Troglitazone on Insulin Sensitivity and Pancreatic β-Cell Function in Women at High Risk for NIDDM

Berkowitz, K. M., Peters, R. K., Kjos, S. L., Goico, J., Marroquin, A., Dunn, M. E., Xiang, A. H., Azen, S. P., & Buchanan, T. A. (1996) · Diabetes · doi:10.2337/diab.45.11.1572 · Cited by 95 · see citing works

Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.

Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Berkowitz, K. M., Marroquin, A., Goico, J., Ochoa, C., & Azen, S. P. (2000) · Diabetes · doi:10.2337/diabetes.49.5.782 · Cited by 111 · see citing works

Effect of Troglitazone on B Cell Function, Insulin Sensitivity, and Glycemic Control in Subjects with Type 2 Diabetes Mellitus

Prigeon, R. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.819 · Cited by 51 · see citing works

Effects of high-dose troglitazone on insulin sensitivity and β-cell function in watanabe heritable hyperlipidemic rabbits

Zhang, B., Shiomi, M., Tanaka, H., Mei, J., Fan, P., Tsujita, Y., Horikoshi, H., & Saku, K. (2001) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190395

Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women

Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339 · see citing works